These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 6753858

  • 1. Comparative efficacy and safety of lofexidine and clonidine given alone or concomitantly with hydrochlorothiazide in hypertensive outpatients.
    Beitman RE, Kuzma RJ, McMahon FG, Morledge J, Mroczek W, Rolf CN, Tsai TH.
    Arzneimittelforschung; 1982; 32(8a):988-93. PubMed ID: 6753858
    [No Abstract] [Full Text] [Related]

  • 2. Lofexidine, a new, antihypertensive imidazoline derivative. Clinical profile of action with single-drug treatment and in combination with hydrochlorothiazide.
    Aigner A, Schmidt U.
    Arzneimittelforschung; 1982; 32(8a):976-83. PubMed ID: 6890373
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative efficacy and safety of lofexidine and clonidine in mild to moderately severe systemic hypertension.
    Lopez LM, Mehta JL.
    Am J Cardiol; 1984 Mar 01; 53(6):787-90. PubMed ID: 6702628
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
    MacKay JH, Arcuri KE, Goldberg AI, Snapinn SM, Sweet CS.
    Arch Intern Med; 1996 Feb 12; 156(3):278-85. PubMed ID: 8572837
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 12; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [A new antihypertensive agent used in a clinical setting].
    Wetzels E, Raschig A, Kaiser HJ.
    Med Klin; 1980 Sep 12; 75(19):688-92. PubMed ID: 7001207
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Enalapril, atenolol and hydrochlorothiazide in mild or moderate hypertension. A comparative multicenter trial in general practice in Norway].
    Helgeland A, Strømmen R, Hagelund CH, Tretli S.
    Tidsskr Nor Laegeforen; 1987 Nov 30; 107(33):2937-40, 2968. PubMed ID: 2829383
    [No Abstract] [Full Text] [Related]

  • 17. Opiate withdrawal using lofexidine, a clonidine analogue with fewer side effects.
    Washton AM, Resnick RB, Geyer G.
    J Clin Psychiatry; 1983 Sep 30; 44(9):335-7. PubMed ID: 6355070
    [Abstract] [Full Text] [Related]

  • 18. Long-term experience with lofexidine in the treatment of mild-to-moderate essential hypertension.
    Lopez LM, Mehta JL.
    Drug Intell Clin Pharm; 1985 Dec 30; 19(12):928-32. PubMed ID: 3910387
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.